retatrutide phase 2 trial results weight loss First 3 data, a Triumph of Science! retatrutide phase 2 trial results

Metformin is a lower-cost option compared to GLP-1 medications, suitable for those seeking modest weight loss or who dont qualify for or prefer to avoid GLP-1 drugs and needles

the regulatory approval process of the FDA and comparable foreign regulatory authorities is lengthy, time-consuming and inherently unpredictable, and even if we complete the necessary clinical studies, we cannot predict when, or if, we will obtain regulatory approval or certification for any of our product candidates, and any such regulatory approval or certification may be for a more narrow indication than we seek

doi: 10.3390/antiox10121899 8

for dulaglutide (Trulicity), within 3 days